Sun Pharma
Search results
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. [2] . Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas.
Dr. Reddy’s Laboratories commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.
17 hours ago · The board of directors of Dr. Reddy's Laboratories will meet on Saturday, July 27 to consider a stock split proposal. Currently, shares of Dr. Reddy's have a face value of ₹5 each. This is the first instance that the company will be carrying out a split of its equity share as a public company.
4 hours ago · Welcome to the Dr. Reddy's Laboratories Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent stock. Dive into the current details of Dr. Reddy's Laboratories, including: Last traded price 6865.0, Market capitalization: 114528.59, Volume: 866091, Price-to-earnings ratio 20.53, Earnings per share 334.35. Our liveblog offers a complete overview of Dr. Reddy's Laboratories through a blend of fundamental and technical indicators. Stay informed ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed...
6 days ago · Hyderabad-based Dr. Reddy’s Laboratories has announced the signing of a non-exclusive patent licensing agreement with Japanese drug maker Takeda Pharmaceutical Company. This collaboration aims to introduce Vonoprazan tablets, a novel treatment for gastrointestinal disorders, to patients across India. Vonoprazan tablets, orally active potassium competitive acid blockers (PCAB), are used to treat reflux esophagitis and other acid peptic disorders. ...
1 day ago · Check out why Dr. Reddys share price is up today. Get all details on Dr. Reddy's Laboratories Ltd.shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC).
17 hours ago · Stocks including Hindustan Unilever, Vedanta, Dr Reddy's, L&T, Axis Bank, Torrent Pharma, Titagarh Railsystems, Bajaj Finance, USL and more will announce their quarterly results on Wednesday, July 24.
